Two Sigma Investments’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Two Sigma Investments’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-87,041	Closed	-$331K	–	3763
2020 Q1	$331K	Sell	87,041 -83,439	-49%	-$359K	﹤0.01%	2221
2019 Q4	$868K	Buy	+170,480	New	+$902K	﹤0.01%	2313
2019 Q2	–	Sell	-409,199	Closed	-$1.9M	–	3834
2019 Q1	$1.9M	Buy	409,199 +23,020	+6%	+$104K	0.01%	1455
2018 Q4	$1.62M	Buy	+386,179	New	+$1.97M	0.01%	1348
2015 Q1	–	Sell	-17,525	Closed	-$132K	–	2959
2014 Q4	$132K	Buy	+17,525	New	+$105K	﹤0.01%	2112
2014 Q1	–	Sell	-23,109	Closed	-$123K	–	2378
2013 Q4	$123K	Buy	+23,109	New	+$102K	﹤0.01%	2071
2013 Q3	–	Sell	-32,629	Closed	-$145K	–	2219
2013 Q2	$145K	Buy	+32,629	New	+$146K	﹤0.01%	1840

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Two Sigma Investments's PGNX Position: Q2 2020 in Review

Two Sigma Investments sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 87,041 shares — an estimated $331K sold.

Two Sigma Investments first reported a position in PGNX in Q2 2013 and held it in 7 quarters. The position peaked at $1.9M in Q1 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Two Sigma Investments reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Two Sigma Investments sold 87,041 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $331K.
Two Sigma Investments first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
Two Sigma Investments's Progenics Pharmaceuticals Inc position peaked at $1.9M in Q1 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Two Sigma Investments's 13F filing for Q2 2020, filed 14 Aug 2020.